BSECompany Update▲ PositiveResults27 Oct 2026
IndiaMART InterMESH Ltd
Please find enclosed herewith the Press Release on the Audited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2026.
IndiaMART InterMESH Ltd reported Q2 FY2027 financial results with consolidated revenue from operations of Rs. 429 Crore, YoY growth of 10%, and net profit of Rs. 91 Crore.
NSEPress Release▲ PositiveResults27 Oct 2026
Indiamart Intermesh Limited
Press Release
IndiaMART InterMESH Limited has announced its financial results for the second quarter ending September 30, 2026, with a 10% YoY growth in consolidated revenue from operations and a 27% YoY growth in standalone net profit.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Oct 2026
Nippon Life India Asset Management Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Nippon Life India Asset Management Limited has announced its Q2 FY27 earnings, with a 25% YoY growth in quarterly operating profit to INR 5.23 bn. The company also declared an interim dividend of INR 9.50 per share. Industry AUM grew by 13% YoY and 5% QoQ in Q2 FY27 to INR 87.2 trillion, with equity AUM increasing by 1% QoQ to 58.2%.
BSEBoard Meeting▲ PositiveResults27 Oct 2026
Siyaram Silk Mills Ltd-$
Outcome of Board Meeting dated 27th October 2026 for Unaudited Financial Results For The Quarter and half year ended 30th September 2026 and other matter
Siyaram Silk Mills Ltd has announced its unaudited financial results for the quarter and half year ended 30th September 2026, with a profit of Rs. 7,495.66 crore and a dividend of Rs. 4 per equity share. The company has also appointed a new Investor Relations (IR) Advisory Company and elevated a senior managerial personnel.
NSEPress Release▲ PositiveOrder Win27 Oct 2026
Indoco Remedies Limited
Press Release
Indoco Remedies Limited's Clinical Research Organisation, AnaCipher, has received approval from ANVISA Brazil for its clinical and bioanalytical facilities.
NSEPress Release▲ PositiveResults27 Oct 2026
Maruti Suzuki India Limited
Press Release
Maruti Suzuki India Limited has announced its Q2 and H1 FY 2026-27 financial results, with the company achieving its highest-ever quarterly and half-yearly sales volume and net sales. The company's domestic market share increased by 2.2 percentage points to 40.8%, and its recently introduced SUVs received a strong market response.
BSECompany Update▲ PositiveResults27 Oct 2026
Maruti Suzuki India Ltd
Maruti Suzuki India Limited Financial Results Q2 and H1 FY 2026-27
Maruti Suzuki India Ltd reported its highest-ever quarterly total sales volume of 696,654 units, registering a growth of 26.5% over the same period previous year. The company's domestic market share increased by 2.2 percentage points to 40.8%. Net Sales for the quarter stood at INR 506,155 million, and Net Profit for the quarter stood at INR 24,149 million.
BSECompany Update▲ PositiveResults27 Oct 2026
Nippon Life India Asset Management Ltd
Please find enclosed the transcript of the earnings call held on October 22, 2026
Nippon Life India Asset Management Ltd has announced its Q2 FY27 earnings, with the company achieving its highest ever quarterly operating profit at INR 5.23 bn, a growth of 25% YoY. The company also declared an interim dividend of INR 9.50 per share. Industry AUM grew by 13% YoY and 5% QoQ in Q2 FY27 to INR 87.2 trillion, with the equity category witnessing a gross inflow of INR 2.69 trillion, higher by 9% QoQ.
BSECompany Update▲ PositiveOrder Win27 Oct 2026
Indoco Remedies Ltd
Indoco''s Clinical Research Orgainsation - AnaCipher receives approval from ANVISA Brazil for its clinical and bioanalytical facilities
Indoco Remedies Ltd's Clinical Research Organisation, AnaCipher, has received approval from ANVISA Brazil for its clinical and bioanalytical facilities.
BSECompany Update▲ PositiveResults27 Oct 2026
Syschem India Ltd
Investor presentation for the quarter ended 30.09.2026
Syschem India Ltd reported a positive turnaround in Q2 FY26-27, with revenue increasing to ₹12,979 lakhs, EBITDA rising to ₹466 lakhs, and PAT recovering to ₹190 lakhs, reversing losses reported in Q1 FY26-27.
BSECompany Update▲ PositiveResults27 Oct 2026
WSFx Global Pay Ltd
Press Release
WSFx Global Pay Ltd reported its unaudited financial results for H1 FY27, with revenue from operations growing 29% to Rs 67.81 crore and Q2 PBT increasing more than ninefold sequentially to Rs 5.33 crore.
BSECompany Update▲ PositiveResults27 Oct 2026
Veefin Solutions Ltd
Veefin Solutions Delivers Blockbuster H1 FY27 Performance- Revenue More Than Doubles, EBITDA Soars - 160% and PAT Surges - 127%
Veefin Solutions Ltd reported a blockbuster H1 FY27 performance with revenue more than doubling, EBITDA soaring 160%, and PAT surging 127%. The company's AI-powered technology ecosystem is positioned for the next phase of growth with a ₹920 crore opportunity pipeline.
BSECompany Update▲ PositiveResults27 Oct 2026
Fairchem Organics Ltd
Please find attached herewith a transcript of audio recording of Earnings Con-call held on Friday, October 23, 2026 for the Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026
Fairchem Organics Ltd has announced its unaudited financial results for Q2 and H1 FY27, showing a 49.7% year-on-year increase in revenue from operations to Rs. 167 crores and a net profit of Rs. 10.2 crores for the quarter. For the half year, revenue from operations increased by 41.4% to Rs. 343 crores, with an EBITDA margin of 10.3% and a net profit of Rs. 21.2 crores.
NSEPress Release▲ PositiveOrder Win27 Oct 2026
Alembic Pharmaceuticals Limited
Press Release
Alembic Pharmaceuticals Limited has received USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL, a significant milestone in the company's growth.
BSECompany Update▲ PositiveOrder Win27 Oct 2026
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL.
Alembic Pharmaceuticals Ltd has received USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL, marking its 227th final approval from the USFDA.
BSEResult▲ PositiveResults27 Oct 2026
Maruti Suzuki India Ltd
Un-audited financial results for the quarter ended on 30th September 2026
Maruti Suzuki India Ltd has announced its unaudited financial results for the quarter ended September 30, 2026, showing a profit of ₹24.15 crore, up from ₹33.03 crore in the same period last year. Revenue from operations stood at ₹533.40 crore, up 1.5% from ₹524.55 crore in the same period last year.
NSEPress Release▲ PositiveResults27 Oct 2026
ACC Limited
Press Release
ACC Limited has announced its Q2 FY27 results, with revenue from operations at Rs 5,689 Cr and operating EBITDA at Rs 401 Cr, with a margin of 7.0%. The company has also commissioned 3.4 MTPA of additional cement capacity and has received shareholder approval for the proposed amalgamation with Ambuja Cements.
BSECompany Update▲ PositiveResults27 Oct 2026
ACC Ltd
"ACC Builds Momentum with Improved Trade Mix, Capacity Expansion and progress on One Cement Platform"
ACC Ltd reported improved trade mix, capacity expansion, and progress on One Cement Platform, with Q2 FY27 cement sales volume at 9.7 MnT, trade share increased by 7 pp YoY to 78%, and blended cement share improved to 85%.
NSEPress Release▲ PositiveProduct Launch27 Oct 2026
LG Electronics India Limited
Press Release
LG Electronics India Limited has introduced its 292 cm (115") QNED evo AI Mini LED TV, the largest model in its 2026 QNED evo lineup, with features such as Precision Dimming Ultra, Dynamic QNED Color Pro, AI Sound Pro, and VRR up to 165Hz.
BSEGeneral▲ PositiveOrder Win27 Oct 2026
Waaree Renewable Technologies Ltd
Please find attached herewith intimation of Receipt of LOA
Waaree Renewable Technologies Ltd has received a Letter of Award (LOA) for a 450 MWp Solar Power Project, with the project scheduled to be completed by 2027-28.